跳到主要內容

臺灣博碩士論文加值系統

(18.97.14.87) 您好!臺灣時間:2025/03/19 21:53
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

我願授權國圖
: 
twitterline
研究生:李岳倫
研究生(外文):YUEH-LUN, LEE
論文名稱:IL-12對氣管發炎動物模式免疫調節機制的探討
論文名稱(外文):The immunoregulatory mechanism of IL-12 on animal model of airway inflammation
指導教授:江伯倫江伯倫引用關係
指導教授(外文):BOR-LUEN, CHIANG
學位類別:博士
校院名稱:國立臺灣大學
系所名稱:微生物學研究所
學門:生命科學學門
學類:微生物學類
論文種類:學術論文
論文出版年:1998
畢業學年度:87
語文別:英文
論文頁數:154
中文關鍵詞:細胞激素IL-12塵璊過敏原百日咳毒素T幫助細胞氣喘嗜伊性白血球抗體基因治療
外文關鍵詞:interleukin-12Der p 1pertussis toxinTh cellasthmaeosinophilantibodygene therapy
相關次數:
  • 被引用被引用:0
  • 點閱點閱:291
  • 評分評分:
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:2
雖然不斷有新的藥劑應用於治療氣喘疾病,在過去二十年間氣喘疾病的發生率仍一直在增加當中。現在的藥物雖能提供疾病症狀的部分舒解,但目前仍企需開發更具專一性的藥劑來遏止過敏性氣喘的發炎反應產生。因此,本研究宗旨即研發IL-12對家塵過敏原Der p 1所引發氣喘發炎動物模式免疫調節機制的探討。首先,利用小鼠建立起家塵過敏原Der p 1誘發的氣管發炎的動物模式,以提供進一步研究IL-12 在生物體的反應。在初步的研究中發現:當用過敏原Der p 1致敏老鼠,初期時即以IL-12注射老鼠時,不僅可促進老鼠體內Th1細胞的免疫反應,亦可抑制由呼吸道給予過敏原致敏所造成的呼吸道發炎現象。更進一步的,我們探討當經IL-12治療的老鼠是否仍可承受多次的過敏原致敏而不引發氣喘症狀的產生;以及測試那些經過敏原致敏導致Th2細胞反應而病發的老鼠,是否仍能因後期接受IL-12注射後而對於病情有改善的現象。由研究資料顯示:IL-12仍可用於治療已病發的老鼠,使呼吸道發炎症狀減輕。然而,另一結果顯示:在老鼠致敏初期注射IL-12並不能永久有效預防過敏性氣喘的發生。此外,為能更進一步的將IL-12應用在基因治療法上,我們利用了基因工程的方法,除了將組成IL-12蛋白質的p35單元體基因及p40單元體基因分別鑲嵌入同一真核載體外,亦另外將設計好的P35和p40組合成的融合基因一起鑲嵌入真核表現載體中。這兩個構築好的真核表現載體分別以pIL-12及pscIL-12代號稱呼之。測試這些質體在生物體內及體外的活性,發現pscIL-12質體不但確實能表現出具有生物活性功能的IL-12融合蛋白質,而且不必擔心有p40單元體的干擾。因此,將來利用pscIL-12質體來進行對過敏疾病的治療可能不失為一更適合的治療方式。
The incidence of asthma has increased substantially in the last two decades, despite increased variety of therapeutic agents. Existing drugs offer partial relief of symptoms in such disease, but there is a great need to develop more specific agents to suppress the inflammatory response in allergic asthma. In this study, we develop a novel therapeutic approach for Der p 1-induced allergic asthma with IL-12 treatment. First, an animal model of airway inflammation induced by house dust mite Der p 1 allergen was established. Then, the in vivo effects of IL-12 on the murine model of asthma were examined. The data demonstrated that IL-12 treatment during antigen sensitization not only promoted Th1 immune responses but also inhibited airway inflammation after a single inhaled antigen challenge. Moreover, the studies were extended to investigate the effects of IL-12 administration to maintain immune responses after multiple allergen challenge and to redirect immune responses after Th2-dominated conditions. The data demonstrated that IL-12 was useful as a therapeutic agent to abolish eosinophil recruitment, despite Th2-associated responses were existed. However, IL-12 could not prevent allergic asthma to maintain a stable and dominated Th1 responses for a long-term time. Furthermore, to apply IL-12 gene in gene therapy, plasmid expressing vectors, expressing coordinately p35 and p40 subunits or a single-chain IL-12 protein, was constructed and designated as pIL-12 or pscIL-12, respectively. The bioactivity of recombinant IL-12 was analyzed both in vitro and in vivo studies. These data revealed that pscIL-12 could encode functional single-chain IL-12 fusion protein and the free p40 subunits which can behave as IL-12 antagonist were negligible. Thus, such pscIL-12 may provide a more appropriate tool in future application of gene therapy for allergic diseases.
封面
中文摘要
英文摘要
誌謝
目錄
縮寫
Chapter I
1-1
1-2
1-3
1-4
1-5
1-6
1-7
Chapter 2 Animal model of airway inflammation induced by house dust mite Der p I allergen
2-2
2-3
2-4
2-5
Chapter 3 Administration of IL-12 prevents mite Der p I allergen-lgE antibody production and airway eosinophils infiltration in animal model of airway inflammation
3-1
3-2
3-3
3-4
3-5
Chapter 4 Administration of interleukin-12 exerts a therapeutic instead of a long-term preventive effect on mite Der p I allergen induced animal model of airway inflammation
4.1
4-2
4-3
4-4
4-5
Chapter 5 Construction of vectors expressing bioactive heterodimeric and single-chain murinem interleukin-12 for gene therapy
5-1
5-2
5-3
5-4
5-5
Chapter 6 Discussion and future work
6-1
6-2
6-3
6-4
References
Adkinson, N. F. Jr., P. A. Eggleston, D. Eney, E. O. Goldstein, K. C. Schuberth, J. R. Bacon, R. G. Hamilton, M. E. Weiss, H. Arshad, C. L. Meinert, J. Tonascia, and B. Wheeler. (1997). A controlled trial of immunotherapy for asthma in allergic children. N. Engl. J. Med. 336:324-331.

Aebischer, I., and B. M. Stadler. (1996). Th1-Th2 in allergic responses: at the limits of a concept. Adv. Immunol. 61:341-403.

Afonso, L. C. C., T. M. Scharton, L. Q. Vieira, M. Wysocka, G. Trinchieri, and P. Scott. (1994). The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263:235-237.

Audibert, F. M., and L. D. Lise. (1993). Adjuvants: current status, clinical perspectives and future prospects. Immunol. Today 14:281-284.

Azzawi, M., B. Bradley, and P. K. Jeffrey. (1990). Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev. Respir. Dis. 142:1407-1413.

Bellone, G., and G. Trinchieri. (1994). Dual stimulatory and inhibitory effect of NK cell stimulatory factor/IL-12 on human hematopoiesis. J. Immunol. 153:930-937.

Bird, R. E., K. D. Hardman, J. W. Jacobson, S. Johnson, B. M. Kaufman, S. M. Lee, T. Lee, S. H. Pope, G. S. Riordan, and W. Whitlow. (1988). Single-chain antigen binding protein. Science 242:423-426.

Bliss, J., V. Van Cleave, K. Murray, A. Wiencis, M. Ketchum, R. Maylor, T. Haire, C. Resmini, A. K. Abbas, and S. F. Wolf. (1996a). IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response. J. Immunol. 156:887-894.

Bliss, J., R. Maylor, K. Stokes, K. S. Murray, M. A. Ketchem, and S. F. Wolf. (1996b). Interleukin-12 as vaccine adjuvant. Ann. N. Y. Acad. Sci. 795:26-35.

Bramson, J., M. Hitt, W. S. Gallichan, K. L. Rosenthal, J. Gauldie, and F. L. Graham. (1996). Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine : in vitro and in vivo production of biologically active interleukin-12. Hum. Gene Ther. 7:333-342.

Brunda, M. J. (1994). Interleukin-12. J Leuko Biol 55:280-288.

Brusselle, G. G., J. C. Kips, G. F. Joos, H. Bluethmann, and R. A. Pauwels. (1995). Allergy-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice. Am. J. Respir. Cell Mol. Biol. 12:254-259.

Burrows, B., M. R. Sears, E. M. Flannery, G. P. Herbison, C. J. Hewitt, and M. D. Holdaway. (1995). Relationship between airway responsiveness and serum IgE in children with asthma and in apparently normal children. N. Engl. J. Med. 325:1067-1071.

Busse, W. W., W. F. Calhoun, and J. D. Sedgwick. (1993). Mechanism of airway inflammation in asthma. Am. Rev. Respir. Dis. 147:S20-24.

Car, B. D., V. M. Eng, B. Schnyder, M. LeHir, A. N. Schakhov, G. Woerly, S. Huang, M. Aguet, T. D. Anderson, and B. Ryffel. (1995). Role of interferon-g in interleukin-12 induced pathology in mice. Am. J. Pathol. 147:1693-1707.

Chan, S. H., B. Perussia, J. W. Gupta, M. Kobayashi, M. Pospisil, H. A. Young, S. F. Wolf, D. Young, S. C. Clark, and G. Trinchieri. (1991). Induction of interferon g production by natural killer cell stimulatory factor : characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:869-879.

Chapman, M. D., and T. A. E. Platts-Mills. (1980). Purification and characterization of the major allergen from Dermatophagoides pteronyssinus-antigen P 1. J. Immunol. 125:587-592.

Chehimi, J., and G. Trinchieri. (1994). Interleukin-12: a bridge between innate resistance and adaptive immunity with a role in infection and acquired immunodeficiency. J. Clin. Immunol. 14:149-161.

Chiang, B. L., H. J. Ding, C. C. Chou, and K. H. Hsieh. (1996). Isolation of type 1 and type 2 cloned mite allergen-specific T cells from an asthmatic child. Pediatr. Allergy Immunol. 7:193-198.

Chow Y. H., W. L. Huang, W. K. Chi, Y. D. Chu, and M. H. Tao. (1997). Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J. Virol. 71:169-178.

Chuang, Y. H., B. L. Chiang, C. C. Chou, and K. H. Hsieh. (1996). Different kinds of antigen-presenting cell exert different effects on T-helper cells development. Int. Arch. Allergy Immunol. 111:366-371.

Chuang, Y. H., B. L. Chiang, C. C. Chou, and K. H. Hsieh. (1997). Immune effector cells induced by complete Freund''s adjuvant exert inhibitory effect on antigen-specific type 2 T helper response. Clin. Exp. Immunol. 27:315-324.

Claudia, Z. A., M. Pretolan, D. Leduc, R. Cordeiro, and B. B. Vargaftig. (1993). Lung responsiveness to antigen in sensitized mice of different strains. Agents Actions 38:C105-107.

Cleric, M., D. R. Lucey, J. A. Berzofsky, L. A. Pinto, T. A. Wynn, S. P. Blatt, M. J. Dolan, C. W. Hendrix, S. F. Wolf, and G. M. Shearer. (1993). Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 262:1721-1724.

Coleman, J. W., M. G. Buckley, M. R. Holliday, and A. G. Morris. (1991). Interferon-gamma inhibits serotonin release from mouse peritoneal mast cells. Eur. J. Immunol. 21:2559-2564.

Constant, S. L., and K. Bottomly. (1997). Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:297-322.

Corrigan, C. J., and A. B. Kay. (1990). CD4+ T-lymphocyte activation in acute severe asthma: relationship to disease severity and atopic status. Am. Rev. Respir. Dis. 141:970-977.

Coyle, A. J., S. Tsuyuki, C. Bertrand, S. Huang, M. Aguet, S. S. Allcan, and G. P. Anderson. (1996). Mice lacking the IFN-gamma receptor have impared ability to resolve a lung eosinophilic inflammatory response associated with a prolonged capacity of T cells to exhibit a Th2 cytokine profile. J. Immunol. 156:2680-2685.

D''Andrea, A., M. Rengaraju, N. M. Valiante, J. Chehimi, M. Kubin, M. Aste-Amezaga, S. H. Chan, M. Kobayashi, D. Young, E. Nickbarg, R. Chizzonite, S. F. Wolf, and G. Trinchieri. (1992). Production of natural killer cell stimulatory factor (NKSF/IL-12) by peripheral mononuclear cells. J. Exp. Med. 76:1387-1398.

Davis, H. L., M. Mancini, M. L. Mickel, and R. G. Whalen. (1996). DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost. Vaccine 14:910-915.

De Waal-Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. De Vries. (1991). Interleukin 10 (IL-10) inhibits cytokines synthesis by human IL-10 produced by monocytes. J. Exp. Med. 174:1209-1220.

Del Prete, G., E. Maggi, P. Parronchi, I. Chretien, A. Tiri, D. Macchia, M. Ricci, J. Banchereau, J. E. De Vries, and S. Romagnani. (1988). IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J. Immunol. 140:4193-4208.

Del Prete, G., E. Maggi, and S. Romagnani. (1994). Human Th1 and Th2 cells : functional properties, mechanisms of regulation, and role in disease. Lab. Invest. 70:299-306.

Desreumaux, P., and M. Capron. (1996). Eosinophils in allergic reactions. Curr. Opin. Immunol. 8:790-795.

Djukanovic, R., W. R. Roche, J. W. Wilson, C. R. Beasley, O. P. Twentyman, R. H. Howarth, and S. T. Holgate. (1990). Mucosal inflammation in asthma. Am. Rev. Respir. Dis. 142:434-457.

Emanuel, M. B., and P. H. Howarth. (1995). Asthma and anaphylaxis: a relevant model for chronic disease? An historical analysis of directions in asthma research. Clin. Exp. Allergy 25:15-26.

Eng, V. M., B. D. Car, B. Schnyder, M. Lorenz, S. Lugli, M. Aguet, T. D. Anderson, B. Ryffel, and V. F. Quesniaux. (1995). The stimulatory effects of interleukin (IL)-12 in hematopoiesis are antagonized by IL-12-induced interferon-g in vivo. J. Exp. Med. 181:1893-1898.

Finkelman, F. D., I. M. Katona, J. F. Urban, Jr. J. Holmes, J. Ohara, A. S. Tung, J. G. Sample, and W. E. Paul. (1988). IL-4 is required to generate and sustain in vivo IgE responses. J. Immunol. 141:2335-2341.

Finkelman, F. D., Jr. J. Holmes, I. M. Katona, Jr. M. P. Beckman, L. S. Park, K. A. Schooley, R. L. Coffman, T. R. Mosmann, and W. E. Paul. (1990). Lymphokine control of in vivo immunoglobulin isotype selection. Ann. Rev. Immunol. 8:303-333.

Finkelman, F. D., K. B. Madden, A. W. Cheever, I. M. Katona, S. C. Morris, M. K. Gately, B. R. Hubbard, W. C. Gause, and J. F. Jr. Urban. (1994). Effects of interleukin-12 on immune responses and host protection in mice infected with intestinal nematode parasites. J. Exp. Med. 179:1563-1572.

Fiorentino, D. F., M. W. Bond, and T. R. Mosmann. (1989). Two types of mouse T helper cell. IV. Th2 clones secret a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:2081-2095.

Garside, P., and A. M. Mowat. (1995). Polarization of Th-cell responses: a phylogenetic consequence of nonspecific immune defense? Immunol. Today 5:220-223.

Gately, M. K., U. Gubler, M. J. Brunda, R. R. Nadeau, T. D. Anderson, J. M. Lipman, and U. Sarmiento. (1994a). Interleukin-12: a cytokine with therapeutic potential in oncology and infectious diseases. Ther. Immunol. 1:187-196.

Gately, M. K., R. R. Warrier, S. Honasoge, D. M. Carvajal, D. A. Faherty, S. E. Connaughton, T. D. Anderson, U. Sarmiento, B. R. Hubbard, and M. Murphy. (1994b). Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-g in vivo. Int. Immunol. 6:157-167.

Gately, M. K., D. M. Carvajal, S. E. Connaughton, S. Gillessen, R. R. Warrier, K. D. Kolinsky, V. L. Wilkin-Son, C. M. Dwyer, G. F. Jr. Higgins, F. J. Podlaski, D. A. Faherty, P. C. Familletti, A. S. Stern, and D. H. Presky. (1996). Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo. Ann. N. Y. Acad. Sci. 795:1-12.

Gavett, S. H., D. J. O''Hearn, L. Xiumin, S-K. Huang, F. D. Finkelman, and M. W. Wills-Karp. (1995). Interleukin-12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med. 182:1527-1536.

Gazzinelli, R. T., M. Wysocka, S. Hayashi, E. Y. Denkers, S. Hieny, P. Caspar, G. Trinchieri, and A. Sher. (1994). Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153:2533-2543.

Gearing, D. P., and D. Cosman. (1991). Homology of the p40 subunit of natural killer cell stimulatory factor (NKSF) with the extracellular domain of the interleukin-6 receptor. Cell 66:9-10.

Germann, T., S. Guckes, M. Bongartz, H. Dlugonska, E. Schmitt, L. Kolbe, E. Kolsch, F. J. Podlaski, M. K. Gately, and E. Rude. (1995a). Administration of IL-12 during ongoing immune responses fails to permanently suppress and can even enhance the synthesis of antigen-specific IgE. Int. Immunol. 7:1649-1657.

Germann, T., M. Bongartz, H. Dlugonska, H. Hess, E. Schmitt, L. Kolbe, E. Kolsch, F. J. Podlaski, M. K. Gately, and E. Rude. (1995b). IL-12 profoundly upregulates the synthesis of antigen-specific, complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo. Eur. J. Immunol. 25:823-829.

Germann, T., and E. Rude. (1995c). Interleukin-12. Int. Arch. Allergy Immunol. 108:103-112.

Gillessen, S., D. CarraJae, P. Ling , F. J. Podlaski, D. L. Stremlo, P. C. Familletti, U. Gubler, P. H. Presky, A. S. Stern, and M. K. Gately. (1995). Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur. J. Immunol. 25:200-206.

Glockshuber, R., M. Malia, I. Pfitzinger, and A. Pluckthun. (1990). A comparison of strategies to stabilize immunoglobulin Fv-fragments. Biochemistry 29: 1362-1367.

Grun, J. L., and P. H. Maurer. (1989). Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: the role of endogenous interleukin 1 in proliferative responses. Cell. Immunol. 121:134-145.

Gubler, U., A. O. Chua, D. S. Schoenhaut, C. M. Dwyer, W. McComas, R. Motyka, N. Nabari, A. G. Wolitzky, P. M. Quinn, P. C. Fanilletti, and M. K. Gately. (1991). Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA 88:4143-4147.

Hall, S. S. (1995). IL-12 at the crossroads. Science 268:1432-1434.

Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. E. Rosser, and M. K. Gately. (1993). Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505-1509.

HayGlase, K. T. (1995). Allergy : who, why and what to do about it ? Immunol. Today 16:505-507.

Hendrzak, J. A., and M. J. Brunda. (1995). Biology of disease: interleukin 12, biologic activity, therapeutic utility, and role in disease. Lab. Invest. 72:619-637.

Hewitt, C. R. A., A. P. Brown, B. J. Hart, and D. I. Pritchard. (1995). A major house dust mite allergen disrupts the immunoglobulin E network by selectively cleaving CD23: innate protection by antiproteases. J. Exp. Med. 182:1537-1544.

Hofstra, C. L., I. Van Ark, G. Hofman, M. Kool, F. P. Nijkamp, and A. J. Van Oosterhout. (1998). Prevention of Th2-like cell responses by coadministration of IL-12 and IL-18 is associated with inhibition of antigen-induced airway hyperresponsiveness, eosinophilia, and serum IgE levels. J. Immunol. 161:5054-5060.

Hogan, S. P., P. S. Foster, X. Tan, and A. J. Ramsay. (1998). Mucosal IL-12 gene delivery inhibits allergic airways disease and restores local antiviral immunity. Eur. J. Immunol. 28:413-423.

Holt, P. G., D. Britten, and J. D. Sedgwick. (1987). Suppression of IgE responses by antigen inhalation : studies on the role of genetic and enviromental factors. Immunology 60:97-102.

Holt, P. G. (1994). A potential vaccine strategy for asthma and allied atopic diseases during early childhood. Lancet 344:456-458.

Hsieh, C. S., S. E. Macatonia, C. S. Tripp, S. F. Wolf, A. O''Garra, and K. M. Murphy. (1993). Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-549.

Hsu, C. H., K. Y. Chua, M. H. Tao, Y. L. Lai, H. D. Wu, S. K. Huang, and K. H. Hsieh. (1996). Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization. Nat. Med. 2:540-544.

Huston, J. S., D. Levinson, M. N. Mudgett-Hunter, R. J. Ridge, R. E. Bruccoleri, E. Haber, and R. Crea. (1988). Protein engineering of antibody binding sites : recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc. Natl. Acad. Sci. USA 85:5879-5883.

Iwama, T., H. Nagai, H. Suda, N. Tsurvoka, and A. Koda. (1992). Effect of murine recombinant interleukin-5 on the cell population in guinea pig airways. Br. J. Pharmacol. 105:19-22.

Iwamoto, I., H. Nakajima, H. Endo, and S. Yoshida. (1993). Interferon g regulates antigen-induced eosinophil recruitment into the mouse airways by inhibiting the infiltration of CD4+ T cells. J. Exp. Med. 177:573-576.

Iwamoto, I., K. Kumano, M. Kasai, K. Kurasawa, and A. Nakao. (1996). Interleukin-12 prevents antigen-induced eosinophil recruitment into mouse airways. Am. J. Respir. Crit. Care Med. 154:1257-1260.

Jeannin, P., Y. Delneste, P. Life, J. -F. Gauchat, D. Kaiserlian, and J. -Y. Bonnefoy. (1995). Interleukin-12 increases interleukin-4 production by established human Th0 and Th2-like T cell clones. Eur. J. Immunol. 25:2247-2252.

Jeannin, P., Y. Delneste, M. Sereso, P. Life, and J-Y. Bonnefoy. (1996). IL-12 synergizes with IL-2 and other stimuli in inducing IL-10 production by human T cells. J. Immunol. 156:3159-3165.

Jirapongsananuruk, O., and D. Y. M. Leung. (1997). Clinical applications of cytokines : new direction in the therapy of atopic diseases. Ann. Allergy Asthma Immunol. 79:5-20.

Kay, A. B. (1991). Asthma and inflammation. J. Allergy Clin. Immunol. 87:893-910.

Kim, T. S., R. H. DeKruyff, R. Rupper, H. T. Maecker, S. Levy, and D. T. Umetsu. (1997). An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominant immune response and inhibiting antigen-specific IgE production. J. Immunol. 158:4137-4144.

Kiniwa, M., M. Gately, U. Gubler, R. Chizzonite, C. Fargeas, and G. Delespesse. (1992). Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes. J. Clin. Invest. 90:262-266.

Kips, J. C., G. J. Brusselle, G. F. Joos, R. A. Peleman, J. A. Tavernier, R. R. Devos, and R. A. Pauwels. (1996). Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice. Am. J. Respir. Crit. Care Med. 153:535-539.

Kobayashi, M., L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. (1989). Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J. Exp. Med. 170:827-845.

Krillis, S., B. A. Baldo, and A. Basten. (1984). Antigens and allergens from the common house dust mite Dermatophagoides pteronyssinus. Part II. Identification of the major IgE binding antigen by crossed radioimmunoelectrophoresis. J. Allergy Clin. Immunol. 74:142-146.

Kubin, M., J. M. Chow, and G. Trinchieri. (1994). Differentional regulation of interleukin 12 (IL-12),tumor necrosis factor a, and IL-1b production in human myeloid leukemia cell lines and peripheral blood mononuclear cells. Blood 83:1847-55.

Lack, G., K. L. Bradley, E. Hamelmann, H. Renz, J. Loader, D. Y. M. Leung, G. Larsen, and E. W. Gelfand. (1996). Nebulized IFN-gamma inhibits the development of secondary allergic responses in mice. J. Immunol. 157:1432-1439.

Lebman, D. A., and R. L. Coffman. (1988). Interleukin 4 causes isotype switching to IgE in T cell-stimulated clonal B cell cultures. J. Exp. Med. 168:853-862.

Ledley, F. D. (1995). Nonviral gene therapy : the promise of gene as pharmaceutical products. Hum. Gene Ther. 6:1129-1144.

Li, X-M., R. K. Chopra, T-Y. Chou, B. H. Schofield, M. Wills-Karp, and S-K. Huang. (1996). Mucosal IFN-g gene transfer inhibits pulmonary allergic responses in mice. J. Immunol. 157:3216-3219.

Lieschke, G. J., P. K. Rao, M. K. Gately, and R. C. Mulligan. (1997). Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo. Nature Biotechnology 15:35-40.

Lind, P., and H. Lowenstein. (1983). Identification of allergens in Dermatophagoides pteronyssinus mite body extract by crossed radioimmuno-electrophoresis with two different rabbits antibody pools. Scand. J. Immunol. 17:263-273.

Ling, P., M. K. Gately, U. Gubler, A. S. Stern, P. Lin, K. Hollfelder, C. Su, Y-C. E. Pan, and J. Hakimi. (1995). Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J. Immunol. 154:116-127.

Lopez, A. F., C. J. Sanderson, J. R. Gamble, H. D. Campbell, I. G. Young, and M. A. Vadas. (1988). Recombinant human interleukin-5 is a selective activator of human eosinophil function. J. Exp. Med. 167:219-224.

Machado, D. C., D. Horton, R. Harrop, P. T. Peachell, and B. A. Helm. (1996). Potential allergens stimulate the release of mediators of the allergic response from cells of mast cell lineage in the absence of sensitization with antigen-specific IgE. Eur. J. Immunol. 26:2972-2980.

Maggi, E., P. Biswas, G. Del Prete, P. Parronchi, D. Macchia, C. Simonelli, L. Emmi, M. De Carli, A. Tiri, M. Ricci, and S. Romagnani. (1991). Accumulation of Th2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J. Immunol. 146:1169-1174.

Manetti, R., P. Parronchi, M. G. Giudizi, M-P. Piccinni, E. Maggi, G. Trinchieri, and S. Romagnani. (1993). Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing cells. J. Exp. Med. 177:1199-1204.

Manetti, R., F. Gerosa, M. G. Giudizi, R. Biagiotti, P. Parronchi, M-P. Piccinni, S. Sampognaro, E. Maggi, S. Romagnani, and G. Trinchieri. (1994). Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones. J. Exp. Med. 179:1273-1283.

Marone, G. (1998). Asthma : recent advances. Immunol. Today 19:5-9.

Marshall, J. D., H. Secrist, R. H. DeKruyff, S. F. Wolf, and D. T. Umetsu. (1995). IL-12 inhibits the production of IL-4 and IL-10 in allergic-specific human CD4+ T lymphocytes. J. Immunol. 155:111-117.

Martinotti, A., A. Stoppacciaro, M. Vagliani, C. Melani, F. Spreafico, M. Wysocka, G. Parmiani, G. Trinchieri, and M. P. Colombo. (1995). CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes. Eur. J. Immunol. 25:137-146.

Matsumoto, K., R. P. Schleimer, H. Saito, Y. Iikura, and B. S. Bochner. (1995). Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood 86:1437-1443.

Mattner, F., S. Fischer, S. Guckes, S. Jin, H. Kaulen, E. Scmitte, E. Rude, and T. Germann. (1993). The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer. Eur. J. Immunol. 23:2202-2208.

McKnight, A. J., G. J. Zimmer, I. Fogelman, S. F. Wolf, and A. K. Abbas. (1994). Effects of IL-12 on helper T cell-dependent immune responses in vivo. J. Immunol. 152:2172-2179.

Merberg, D. M., S. F. Wolf, and S. C. Clark. (1992). Sequence similarity between NKSF and the IL-6/G-CSF family. Immunol. Today 13:77-78.

Mickel, M. L., H. L. Davis, M. Schleef, M. Mancini, P. Tiollais, and R. G. Whalen. (1995). DNA-mediated immunization to the hepatitis B surface antigen in mice : aspects of the humoral response mimic hepatitis B viral infection in humans. Proc. Natl. Acad. Sci. USA 92:5307-5311.

Morris, S. C., K. B. Madden, J. J. Adamovicz, W. C. Gause, B. R. Hubbard, M. K. Gately, and F. D. Finkelman. (1994). Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J. Immunol. 152:1047-1056.

Mu, H. H., and W. A. Sewell. (1993). Enhancement of interleukin-4 production by pertussis toxin. Infect. Immun. 61:2834-2840.

Mu, H. H., and W. A. Sewell. (1994). Regulation of DTH and IgE responses by IL-4 and IFN-g in immunized mice given pertussis toxin. Immunology 83:639-645.

Munoz, J. J., H. Arai, R. K. Bergman, and P. I. Sadowski. (1981). Biological activities of crystalline pertussigen from Bordetella pertussis. Infect. Immun. 33:820-826.

Munoz, J. J., C. C. A. Bernard, and I. R. Mackay. (1984). Elicitation of experimental allergic encephalomyelitis (EAE) in mice with the aid of pertussigen. Cell Immunol. 83:92-100.

Nabors, G. S., L. C. C. Afonso, J. P. Farrell, and P. Scott. (1995). Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and pentostam. Proc. Natl. Acad. Sci. USA 92:3142-3146.

Nadel, J. A., and W. W. Busse. (1998). Asthma. Am. J. Respir. Crit. Care. Med. 157:S130-138.

O''Brien, R. M., and W. R. Tomas. (1994). Immune reactivity to Der p I and Der p II in house dust mite sensitive patients attending paediatric and adult allergy clinics. Clin. Exp. Allergy 24:737-742.

Oettgen, H. C., T. R. Martin, A. Wynshaw-Boris, C. Deng, J. M. Drazen, and P. Leder. (1994). Active anaphylaxis in IgE-deficient mice. Nature 70:367-370.

O''Garra, A., and K. Murphy. (1994). Role of cytokines in determining T lymphocyte function. Curr. Opin. Immunol. 6:458-466.

Oswald, I. P., P. Caspar, D. Jankovic, T. A. Wynn, E. J. Pearce, and A. Sher. (1994). IL-12 inhibits Th2 cytokine responses induced by egg of Schistosoma mansoni. J. Immunol. 153:1707-1713.

Pantoliano, M. W., R. E. Bird, L. S. Johnson, E. D. Asel, S. W. Dodd, J. F. Wood, and K. D. Hardman. (1991). Conformational stability, folding, and ligand-binding affinity of single-chain Fv immunoglobulin fragments expressed in Escherichia coli. Biochemistry 30:10117-10125.

Parronchi, P., D. Macchia, M. P. Piccinni, P. Biswas, C. Simonelli, E. Maggi, M. Ricci, A. A. Ansari, and S. Romagnani. (1991). Allergen-and bacterial antigen-specific T-cell clones established from atopic donors show different profile of cytokine production. Proc. Natl. Acad. Sci. USA 88: 4538-4542.

Parronchi, P., M. De Carli, R. Manetti, C. Simonelli, M. P. Piccinni, D. Macchia, E. Maggi, G. Del Prete, M. Ricci, and S. Romagnani. (1992). Aberrant interleukin (IL)-4 and IL-5 production in vitro by CD4+ helper T cells from atopic subjects. Eur. J. Immunol. 22:1615-1620.

Perez, V. L., J. A. Lederer, A. H. Lichtman, and A. K. Abbas. (1995). Stability of Th1 and Th2 population. Int. Immunol. 7:869-875.

Platts-Mills, T. A., M. J. Snajdr, K. Ishizaka, and A. W. Frankland. (1978). Measurement of IgE antibody by an antigen-binding assay : correlation with PK activity and IgG and IgA antibodies to allergens. J. Immunol. 120:1201-1210.

Raz, E., H. Tighe, Y. Sato, M. Corr, J. A. Dudler, M. Roman, S. L. Swain, H. L. Spiegelberg, and D. A. Carson. (1996). Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc. Natl. Acad. Sci. USA 93:5141-5145.

Rempel, J. D., M-D. Wang, and K. T. HayGlass. (1997). In vivo IL-12 administration induces profound but transient commitment to T helper cell type 1-associated patterns of cytokines and antibody production. J. Immunol. 159:1490-1496.

Ricci, M., O. Rossi, M. Bertoni, and A. Matucci. (1993). The importance of Th2-like cells in the pathogenesis of airway allergic inflammation. Clin. Exp. Allergy 23:360-369.

Robinson, D. S., Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A. M. Bentley, C. Corrigan, S. R. Durham, and A. B. Kay. (1992). Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298-304.

Ryan, M. S., F. Griffin, B. Mahon, and K. H. G. Mills. (1997). The role of the S-1 and B-oligomer components of pertussis toxin in its adjuvant properties for Th1 and Th2 cells. Biochemical Society Transactions 126S:25.

Samore, M. H., and G. R. Siber. (1996). Pertussis toxin enhanced IgG1 and IgE responses to primary tetanus immunization are mediated by interleukin-4 and persist during secondary response to tetanus alone. Vaccine 14:290-297.

Sarmiento, U. M., J. H. Riley, P. A. Knaack, J. M. Lipman, J. M. Beeker, M. K. Gately, R. Chizzonite, and T. D. Anderson. (1994). Biologic effects of recombinant human interleukin-12 in squirrel monkeys (Sciureus saimiri). Lab. Invest. 71:862-873.

Schijns, V. E. C. J., B. L. Haagmans, and M. C. Horzinek. (1995). IL-12 stimulates an antiviral type 1 cytokine response but lacks adjuvant activity in IFN-g-receptor-deficient mice. J. Immunol. 155:2525-2532.

Schmitt, E., P. Hoehn, T. Germann, and E. Rude. (1994). Differential effects of interleukin-12 on the development of naive mouse CD4+ T cells. Eur. J. Immunol. 24:343-347.

Schoenhaut, D. S., A. O. Chua, A. G. Wolitzky, M. Phyllis, P. M. Guinn, C. M. Dwyer, W. McComas, P. C. Familletti, M. K. Gately, and U. Gubler. (1992). Cloning and expression of murine IL-12. J. Immunol. 148:3433-3440.

Schulz, O., B. J. Sutton, R. L. Beavil, J. Shi, H. F. Sewell, H. J. Gould, P. Laing, and F. Skakib. (1997). Cleavage of the low affinity receptor for human IgE (CD23) by a mite cysteine protease : nature of the cleaved fragment in relation to the structure and function of CD23. Eur. J. Immunol. 27:584-588.

Schulz, O., H. F. Sewell, and F. Shakib. (1998). Proteolytic Cleavage of CD25, the a subunit of the human T cell interleukin 2 receptor, by Der p 1, a major mite allergen with cysteine protease activity. J. Exp. Med. 187:271-275.

Schwarze, J., E. Hamelmann, G. Cieslewicz, A. Tomkinson, A. Joetham, K. Bradley, and E. W. Gelfand. (1998). Local treatment with IL-12 is an effective inhibitor of airway hyperresponsiveness and lung eosinophilia after airway challenge in sensitized mice. J. Allergy Clin. Immunol. 102:86-93.

Scott, P. (1993). Selective differentiation of CD4+ T helper cell subsets. Curr. Opin. Immunol. 5:391-397.

Sear, M. R., G. P. Hervison, M. D. Holdaway, C. J. Hewitt, E. M. Flannery, and P. A. Silva. (1989). The relative risks of sensitivity to grass pollen, house dust mite, and cat dander in the development of childhood asthma. Clin. Exp. Allergy 19:419-424.

Sears, M. R., B. Burrows, and E. M. Flannery. (1991). Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children. N. Engl. J. Med. 325:1067-1071.

Secrist, H., C. J. Chelen, Y. Wen, J. D. Marshall, and D. T. Umetsu. (1993). Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J. Exp. Med. 178:2123-2130.

Seder, R. A., W. E. Paul, M. M. Davis, de S. T. Fazekas, and B. Groth. (1992). The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. J. Exp. Med. 176:1091-1098.

Seder, R. A., R. Gazzinelli, A. Sher, and W. E. Paul. (1993). Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90:10188-10192.

Sedgwick, J. D., and P. G. Holt. (1983). Induction of IgE-isotype specific tolerance by passive antigenic stimulation of the respiratory mucosa. Immunology 50:625-630.

Sewell, J. J., C. C. A. Bernard, and I. R. Mackay. (1983). Enhancement of the intensity, duration and passive transfer of delayed type hypersensitivity by pertussigen in mice. J. Exp. Med. 157:2087-2096.

Shakib, F., O. Schulz, and H. Sewell. (1998). A mite subversive: cleavage of CD23 and CD25 by Der p 1 enhances allergenicity. Immunol. Today 19:313-316.

Smith, H. (1992). Asthma, inflammation, eosinophils and bronchial hyperresponsiveness. Clin. Exp. Allergy 22:187-197.

Smith, J. M., M. E. Disney, J. D. Williams, and Z. A. Goels. (1969). Clinical significance of skin reactions to mite extracts in children asthma. Brit. Med. J. 1:723-726.

Stern, A. S., F. J. Podlaski, J. D. Hulmes, Y-C. E. Pan, P. M. Quinn, A. G. Wolitzky, P. C. Familletti, D. L. Stremlo, T. Truitt, R. Chizzonite, and M. K. Gately. (1990). Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 87:6808-6812.

Stern, A. S., J. Magram, and D. H. Presky. (1996). Interleukin-12: an integral cytokine in the immune response. Life Sciences 58:639-654.

Stevens, T. L., A. Bossie, V. M. Sanders, R. Fernandez-Botran, R. L. Coffman, T. R. Mosmann, and E. S. Vitetta. (1988). Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 334:255-258.

Stewart, G. A., and P. G. Holt. (1987). Immunogenicity and tolerogenicity of a major house dust mite allergen, Der p I from Dermatophagodies pteronyssinus, in mice and rat. Int. Arch. Allergy Appl. Immunol. 83:44-51.

Sur, S., J. Lam, P. Bouchard, A. Sigounas, D. Holbert, and W. J. Metzger. (1996). Immunomodulatory effects of IL-12 on allergic lung inflammation depend on timing of doses. J. Immunol. 157:4173-4180.

Swain, S. L. (1993). IL-4 dictates T-cell differentiation. Res. Immunol. 144:616-620.

Swain, S. L. (1994). Generation and in vivo persistence of polarized Th1 and Th2 memory. Immunity 1:543-552.

Sypek, J. P., C. L. Chung, S. E. H. Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburth, S. F. Wolf, and R. G. Schaub. (1993). Resolution of cutaneous Leishmaniasis : interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177:1797-1802.

Tan, J., C. A. Newton, J. Y. Djeu, D. E. Gutsch, A. E. Chang, N. S. Yang, T. W. Klein, and Y. Hua. (1996). Injection of complementary DNA encoding interleukin-12 inhibits tumor establishment at a distant site in a murine renal carcinoma model. Cancer Reserach 56:3399-3403.

Thomas, W. R., W. Smith, and B. J. Hales. (1998). House dust mite allergen characterization: implications for T-cell responses and immunotherapy. Int. Arch. Allergy Immunol. 115:9-14.

Tominaga, A., S. Takaki, N. Koyama, D. Katoh, R. Matsumoto, M. Migita, Y. Hitoshi, S. Yamauchi, Y. Kanai, J. I. Miyazaki, G. Usuku, K. I. Yamamura, and K. Takatsu. (1991). Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin-5) develop eosinophilia and auto-antibody production. J. Exp. Med. 173:429-437.

Tovey, E. R., M. D. Chapman, and T. A. E. Platts-Mills. (1981). Mite faeces are a major source of house dust allergens. Nature 289:592-593.

Voorhorst, R., M. I. A. Spieksma-Boezeman, and F. Th. M. Spieksma. (1964). Is a mite (Dermatophagoides sp) the producer of the house dust allergen? Allergy Asthma 10:329-334.

Voorhorst, R., F. Th. M. Spieksma, H. Varekamp, M. J. Leupen, and A. W. Lyklema. (1967). The house dust mite (Dermatophagoides pteronyssinus) and the allergens it produces. Identity with the house dust allergen. J. Allergy 39:325-339.

Walker, C., E. Bode, L. Boer, T. T. Hansel, K. Blaser, and J. C. Jr. Virchow. (1992). Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am. Rev. Respir. Dis. 146:109-115.

Wang, J. M., A. Rambaldi, A. Biondi, Z. G. Chen, C. J. Sanderson, and A. Mantovani. (1989). Recombinant human interleukin-5 is a selective eosinophil chemoattractant. Eur. J. Immunol. 19:701-705.

Wardlaw, A. J., S. Dunnette, G. J. Gleich, J. V. Collins, and A. B. Kay. (1988). Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma : relationship to bronchial hyperreactivity. Am. Rev. Respir. Dis. 137:62-69.

Warren, H. S., F. R. Vogel, and L. A. Chedid. (1986). Current status of immunological adjuvants. Annu. Rev. Immunol. 4:369-388.

Whitlow, M., B. A. Bell, S. -L. Feng, D. Filpula, K. D. Hardman, S. L. Hubert, M. Rollence, J. F. Wood, M. E. Schott, D. E. Milenic, T. Yokota, and J. Schlom. (1993). An improved linker for single-chain Fv with reduced aggregation and enhance proteolytic stability. Protein Eng. 6:989-995.

Wilson, J. M. (1996). Adenoviruses as gene-delivery vehicles. New. Engl. J. Med. 334:1185-7.

Wolf, S. F., P. A. Temple, M. Kobayashi, D. Young, M. Dicig, L. Lowe, R. Dzialo, L. Fitz, C. Ferenz, R. M. Hewick, K. Kelleher, S. H. Herrmann, S. C. Clark, L. Azzoni, S. H. Chan, G. Trinchieri, and B. Perussia. (1991). Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146: 3074-3081.

Wolf, S. F., D. Sieburth, and J. Sypek. (1994). Interleukin 12 : a key modulator of immune function. Stem Cells 12:154-168.

Wu, C. Y., C. E. Demeure, M. Gately, F. Podlaski, H. Yssel, M. Kiniwo, and G. Delespesse. (1994). In vitro maturation of human neonatal CD4 T lymphocytes. I. Induction of IL-4-producing cells after long-term culture in the presence of IL-4 plus either IL-2 or IL-12. J. Immunol. 152:1141-1153.

Wynn, T. A., I. Eltoum, I. P. Oswald, A. W. Cheever, and A. Sher. (1994). Endogenous interleukin-12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J. Exp. Med. 179:1551-1561.

Wynn, T. A., D. Jankovic, S. Hieny, A. W. Cheever, and A. Sher. (1995). IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia. J. Immunol. 154:4701-4709.

Yu, C. K., S. C. Lee, J. Y. Wang, T. R. Hsiue, and H. Y. Lei. (1996). Early-type hypersensitivity-assocoated airway inflammation and eosinophilia induced by Dermatophagoides farinae in sensitized mice. J. Immunol. 156:1923-1930.

Yu, P., M. Kosco-Vilbois, M. Richards, G. Kohler, and M. C. Lamers. (1994). Negative feedback regulation of IgE synthesis by murine CD23. Nature 369:753-756.

Zhou, P., M. C. Sieve, J. Bennett, K. J. Kwon-Chung, R. P. Tewari, R. T. Gazzinelli, A. Sher, and R. A. Seder. (1995). IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-g. J. Immunol. 155:785-795.

Zitvogel, L., H. Tahara, Q. Cai, W. J. Storkus, G. Muller, S. F. Wolf, M. Gately, P. D. Robbins, and M. T. Lotze. (1994). Construction and characterization of retroviral vectors expressing biologically active human interleukin 12. Hum. Gene. Ther. 5:1493-1506.

Zou, J. J., D. S. Schoenhaut, D. M. Carvajal, R. R. Warrier, D. H. Presky, M. K. Gately, and U. Gubler. (1995). Sructure-function analysis of the p35 subunit of mouse interlukin 12. J. Biol. Chem. 270:5864-5871.
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
無相關期刊